Symposia: Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Translational Research, Combination therapy, Diseases, Therapies, Myeloid Malignancies
Type: Oral
Hematology Disease Topics & Pathways:
Research, Translational Research, Combination therapy, Diseases, Therapies, Myeloid Malignancies
Sunday, December 10, 2023: 9:30 AM-11:00 AM
Pacific Ballroom Salons 24-26
(Marriott Marquis San Diego Marina)
Moderators:
Courtney L Jones, PhD, Cincinnati Children's Hospital Medical Center
and
Nicole R. Grieselhuber, MD, PhD, The Ohio State University Comprehensive Cancer Center
Disclosures:
No relevant conflicts of interest to declare.
Development of therapy resistance remains a major hurdle in the treatment of myeloid malignancies. In this session approaches to overcome therapy resistance to agents including chemotherapy, hypomethylating agents, and venetoclax will be presented.
9:30 AM
10:00 AM
10:15 AM
10:30 AM
10:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH